Candida antigen

Drug Profile

Candida antigen

Alternative Names: Candida albicans antigen; Candida albicans skin test antigen; Candin

Latest Information Update: 25 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nielsen BioSciences
  • Class Antigens; Immunotherapies; Yeasts
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Hypersensitivity
  • Phase II Warts

Most Recent Events

  • 15 May 2017 Phase-II development is ongoing in USA (NCT02393417)
  • 01 Feb 2015 Phase-II clinical trials in Warts in USA (Intralesional) (NCT02393417)
  • 12 Jan 1995 Launched for Hypersensitivity (Diagnosis) in USA (Intradermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top